PRECISION BIOSCIENCES INC (DTIL) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
31/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinDTIL / S&P 42.91% / 15.20% |
WinDTIL / S&P 3472.96% / 15.00% |
LoseDTIL / S&P -86.39% / 50.40% |
| 2026-Q11/3 |
WinDTIL / S&P 32.21% / -4.33% |
LoseDTIL / S&P -11.87% / 11.30% |
LoseDTIL / S&P -15.42% / 27.70% |
| 2025-Q40/3 |
LoseDTIL / S&P -24.64% / 2.65% |
LoseDTIL / S&P -50.12% / 9.00% |
LoseDTIL / S&P -360.87% / 13.40% |
| 2025-Q31/3 |
WinDTIL / S&P 31.43% / 8.12% |
LoseDTIL / S&P -99.07% / 4.61% |
LoseDTIL / S&P -14966.67% / 13.45% |
| 2025-Q20/3 |
LoseDTIL / S&P -11.95% / 10.94% |
LoseDTIL / S&P -98.56% / 4.83% |
LoseDTIL / S&P -4542.86% / 10.63% |
| 2025-Q11/3 |
WinDTIL / S&P 25.20% / -4.27% |
LoseDTIL / S&P -11.11% / 4.98% |
LoseDTIL / S&P -66.67% / 10.57% |
| 2024-Q41/3 |
LoseDTIL / S&P -57.48% / 2.41% |
WinDTIL / S&P 40.98% / 5.25% |
LoseDTIL / S&P -108.60% / 6.15% |
| 2024-Q31/3 |
LoseDTIL / S&P -7.91% / 5.89% |
WinDTIL / S&P 43.62% / 5.89% |
LoseDTIL / S&P -100.12% / 6.11% |
| 2024-Q21/3 |
LoseDTIL / S&P -28.24% / 4.28% |
WinDTIL / S&P 88.35% / 5.38% |
LoseDTIL / S&P -100.45% / 5.12% |
| 2024-Q12/3 |
WinDTIL / S&P 23.84% / 10.56% |
WinDTIL / S&P 88.25% / 5.71% |
LoseDTIL / S&P -82.94% / 5.59% |
| 2023-Q41/3 |
LoseDTIL / S&P 7.04% / 11.69% |
WinDTIL / S&P 94.15% / 6.81% |
LoseDTIL / S&P -58.01% / 7.78% |
| 2023-Q32/3 |
LoseDTIL / S&P -35.17% / -3.27% |
WinDTIL / S&P 150.91% / 7.52% |
WinDTIL / S&P 3126.32% / -5.03% |
| 2023-Q22/3 |
LoseDTIL / S&P -30.24% / 8.74% |
WinDTIL / S&P 24.04% / 9.50% |
WinDTIL / S&P 3065.10% / -8.57% |
| 2023-Q11/3 |
LoseDTIL / S&P -36.64% / 7.50% |
LoseDTIL / S&P -70.18% / 10.77% |
WinDTIL / S&P 6540.30% / -15.69% |
| 2022-Q40/3 |
LoseDTIL / S&P -8.46% / 7.56% |
LoseDTIL / S&P -78.28% / 11.88% |
LoseDTIL / S&P DTIL unavailable / -17.99% |
| 2022-Q30/3 |
LoseDTIL / S&P -18.75% / -4.88% |
LoseDTIL / S&P -82.35% / 13.47% |
LoseDTIL / S&P DTIL unavailable / -1.41% |
| 2022-Q20/3 |
LoseDTIL / S&P -48.05% / -16.10% |
LoseDTIL / S&P -62.99% / 13.71% |
LoseDTIL / S&P DTIL unavailable / 11.04% |
| 2022-Q11/3 |
LoseDTIL / S&P -58.38% / -4.60% |
WinDTIL / S&P 204.72% / 15.97% |
LoseDTIL / S&P DTIL unavailable / 42.23% |
| 2021-Q41/3 |
LoseDTIL / S&P -35.88% / 11.03% |
WinDTIL / S&P 375.72% / 15.00% |
LoseDTIL / S&P DTIL unavailable / 96.40% |
| 2021-Q31/3 |
LoseDTIL / S&P -7.83% / 0.58% |
WinDTIL / S&P 437.48% / 10.77% |
LoseDTIL / S&P DTIL unavailable / 69.42% |
| 2021-Q22/3 |
WinDTIL / S&P 20.97% / 8.55% |
WinDTIL / S&P 420.80% / 6.58% |
LoseDTIL / S&P DTIL unavailable / 51.81% |
| 2021-Q12/3 |
WinDTIL / S&P 24.10% / 6.17% |
WinDTIL / S&P 41.48% / -1.06% |
LoseDTIL / S&P DTIL unavailable / 7.39% |
| 2020-Q42/3 |
WinDTIL / S&P 35.39% / 12.15% |
WinDTIL / S&P 9.20% / -3.72% |
LoseDTIL / S&P DTIL unavailable / -33.42% |
| 2020-Q31/3 |
LoseDTIL / S&P -26.05% / 8.93% |
WinDTIL / S&P 6.32% / -2.04% |
LoseDTIL / S&P DTIL unavailable / -27.10% |
| 2020-Q22/3 |
WinDTIL / S&P 38.14% / 20.54% |
WinDTIL / S&P 6.17% / -0.46% |
LoseDTIL / S&P DTIL unavailable / -27.11% |
| 2020-Q11/3 |
LoseDTIL / S&P -56.59% / -19.60% |
WinDTIL / S&P 60.45% / 3.47% |
LoseDTIL / S&P DTIL unavailable / -14.75% |
| 2019-Q42/3 |
WinDTIL / S&P 65.55% / 9.07% |
WinDTIL / S&P 104.34% / 5.36% |
LoseDTIL / S&P DTIL unavailable / 2.99% |
| 2019-Q30/3 |
LoseDTIL / S&P -36.68% / 1.70% |
LoseDTIL / S&P DTIL unavailable / 5.02% |
LoseDTIL / S&P DTIL unavailable / 0.21% |
| 2019-Q20/3 |
LoseDTIL / S&P -26.18% / 4.30% |
LoseDTIL / S&P DTIL unavailable / 6.64% |
LoseDTIL / S&P DTIL unavailable / 8.65% |
| 2019-Q10/3 |
LoseDTIL / S&P DTIL unavailable / 13.65% |
LoseDTIL / S&P DTIL unavailable / 8.12% |
LoseDTIL / S&P DTIL unavailable / 14.29% |
| 2018-Q40/3 |
LoseDTIL / S&P DTIL unavailable / -13.52% |
LoseDTIL / S&P DTIL unavailable / 9.05% |
LoseDTIL / S&P DTIL unavailable / 18.23% |
| 2018-Q30/3 |
LoseDTIL / S&P DTIL unavailable / 7.71% |
LoseDTIL / S&P DTIL unavailable / 10.21% |
LoseDTIL / S&P DTIL unavailable / 19.06% |
| 2018-Q20/3 |
LoseDTIL / S&P DTIL unavailable / 3.43% |
LoseDTIL / S&P DTIL unavailable / 9.03% |
LoseDTIL / S&P DTIL unavailable / 14.46% |
| 2018-Q10/3 |
LoseDTIL / S&P DTIL unavailable / -0.76% |
LoseDTIL / S&P DTIL unavailable / 7.68% |
LoseDTIL / S&P DTIL unavailable / 12.46% |
| 2017-Q40/3 |
LoseDTIL / S&P DTIL unavailable / 6.64% |
LoseDTIL / S&P DTIL unavailable / 7.03% |
LoseDTIL / S&P DTIL unavailable / 13.82% |
| 2017-Q30/3 |
LoseDTIL / S&P DTIL unavailable / 4.48% |
LoseDTIL / S&P DTIL unavailable / 5.68% |
LoseDTIL / S&P DTIL unavailable / 17.57% |
| 2017-Q20/3 |
LoseDTIL / S&P DTIL unavailable / 3.09% |
LoseDTIL / S&P DTIL unavailable / 4.83% |
LoseDTIL / S&P DTIL unavailable / 17.74% |
| 2017-Q10/3 |
LoseDTIL / S&P DTIL unavailable / 6.07% |
LoseDTIL / S&P DTIL unavailable / 3.67% |
LoseDTIL / S&P DTIL unavailable / 13.32% |
| 2016-Q40/3 |
LoseDTIL / S&P DTIL unavailable / 3.82% |
LoseDTIL / S&P DTIL unavailable / 2.09% |
LoseDTIL / S&P DTIL unavailable / 7.05% |
| 2016-Q30/3 |
LoseDTIL / S&P DTIL unavailable / 3.85% |
LoseDTIL / S&P DTIL unavailable / 0.20% |
LoseDTIL / S&P DTIL unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | DTIL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 71.43% | 20.78% |
| Annualized return | 71.43% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | DTIL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.95% | 83.14% |
| Annualized return | -54.06% | 12.86% |
10Y · 2019-03-28 to 2026-08-27
| Metric | DTIL total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.39% | 319.30% |
| Annualized return | -33.85% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |